There are 2789 resources available
147P - Genomic profile and response prediction of eribulin mesylate-based neoadjuvant chemotherapy in triple-negative breast cancer patients
Presenter: Tomomi Nishimura
Session: ePoster Display
148P - Phase III study of everolimus or placebo in addition to adjuvant hormone therapy for high risk early breast cancer: Subgroup analysis of the UCBG UNIRAD trial
Presenter: Paul Cottu
Session: ePoster Display
149P - Can high Ki67 predict distant recurrence in early stage breast cancer with low oncotype Dx score?
Presenter: Parvaneh Fallah
Session: ePoster Display
150P - Dysregulation of immune checkpoint proteins in newly-diagnosed early breast cancer patients
Presenter: Bernardo Rapoport
Session: ePoster Display
151P - The impact of limb hypothermia on the incidence and severity of paclitaxel induced peripheral neuropathy in breast cancer patients
Presenter: Alzahraa Azab
Session: ePoster Display
152P - Meta-analysis of the prognostic value of circulating tumor DNA (ctDNA) in patients (pts) with early breast cancer (EBC)
Presenter: Nadia Saoudi Gonzalez
Session: ePoster Display
153P - Adjuvant endocrine therapy combined with abemaciclib in monarchE patients with high-risk early breast cancer: Disease characteristics and endocrine therapy choice by menopausal status
Presenter: Shani Paluch-Shimon
Session: ePoster Display
105P - Prognostic value of the NTRK fusion biomarker in the Netherlands
Presenter: Irene Santi
Session: ePoster Display
106P - Prognostic impact of memory CD8(+) T cells on immunotherapy in human cancers: A systematic review and meta-analysis
Presenter: Yao Jin
Session: ePoster Display
107P - Co-mutation of IDH1 and DNA damage repair genes in patients with hepatobiliary cancer implicates longer overall survival
Presenter: Guangming Li
Session: ePoster Display